Cross-referencing clinical data
EarlyT4D Myoviridae Bacteriophage
T4D Myoviridae Bacteriophage.
A well-studied phage type that targets E. coli, helping keep pathogenic strains in check. Targets and destroys pathogenic E. coli strains in the gut. Leaves beneficial bacteria alone.
EarlyResearch strength
Reviewed March 2026
- Category
- General
- Also filed under
- E. coli targetingMicrobiome balanceWell-characterized mechanism
What T4D Myoviridae Bacteriophage is, and what it does.
- Does it work
- The most scientifically famous phage, but supplement applications are still early.
- How much to take
- Measured in PFU. Part of multi-phage cocktails. Follow product directions.
- The first dose
- Nothing you'd notice.
- With regular use
- Potential reduction in pathogenic E. coli over weeks. Limited supplement-specific data.
- How well tolerated
- Well tolerated. T4 phages have been studied for decades with no safety concerns.
- How it feels
- Invisible at work. Any benefit manifests as gradually better gut function.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Kills pathogenic E. coli
- Improves gut health via supplements
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.
Questions people ask about T4D Myoviridae Bacteriophage.
- Why is T4 so famous?
- It's the most studied virus in scientific history. Most of what we know about viral genetics came from T4 research. It's the lab rat of the virus world.
- Will this kill ALL my E. coli?
- No. T4D targets specific pathogenic strains. Many E. coli strains in your gut are beneficial (like those that make vitamin K). Phages are strain-specific.
- Is this safe if I'm healthy?
- Yes. You're already ingesting T4 phages daily through food and water. Adding more through a supplement isn't introducing anything foreign.
- How is T4D different from regular T4?
- T4D is a specific variant of the T4 phage selected for supplement use. Same family, slightly different characteristics optimized for oral delivery.
- Do phage supplements actually work?
- The mechanism is proven (phages kill specific bacteria). Whether supplement doses meaningfully shift your microbiome is less clear. Promising but still early.
- Can bacteria become resistant to T4?
- Yes, bacteria can evolve resistance. That's why multi-phage cocktails use several different phages together, making resistance much harder to develop.
Nothing to show here, and the reason why.
A pairing appears on this page only when a trial gave both ingredients together and measured the result. T4D Myoviridae Bacteriophage has none that clears that bar.
No pairing for T4D Myoviridae Bacteriophage has cleared review yet.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
Plays well withEstablished knowledge, not a trial
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
T4D Myoviridae Bacteriophage + Probioticsphage clears a competing coliform niche
T4D is a T4 type lytic phage of Escherichia coli, so it lyses the target coliform and releases its contents into the lumen. Delivered probiotic strains are outside its host range and are positioned to use the freed nutrients and surface.
T4D Myoviridae Bacteriophage + Lactobacillus plantarumselective lysis of a competitor, not the probiotic
T4 type phages adsorb to outer membrane and lipopolysaccharide structures that Gram positive lactobacilli do not have, so the delivered strain is unaffected. The phage narrows competition in the shared niche.
T4D Myoviridae Bacteriophage + bifidobacterium-longumEstablished phage host specificity: T4-type coliphages infect Escherichia coli and do not infect Gram-positive bifidobacteria.
T4-type phages recognise specific surface receptors on E. coli and cannot attach to bifidobacteria, so a probiotic strain co-delivered with the phage is not a target. That non-overlap is the whole rationale for pairing a narrow-spectrum phage with a live culture rather than with a broad antibacterial. Whether the pairing changes any measured gut outcome is a separate question the specificity does not answer.
T4D Myoviridae Bacteriophage + bifidobacterium-lactisHost range of T4-type coliphages excludes Gram-positive genera.
The phage replicates only inside a susceptible E. coli host cell, so a co-formulated Bifidobacterium is chemically and biologically untouched by it. Formulators use this to combine the two in one capsule. Compatibility is established; a combined benefit is not.
T4D Myoviridae Bacteriophage + lactobacillus-acidophilusNon-overlapping host range between a coliphage and a lactobacillus.
Coliphages need Gram-negative envelope receptors that lactobacilli do not present. The two therefore coexist in a blend without the phage reducing the delivered live count. This is compatibility, not a demonstrated additive effect.
T4D Myoviridae Bacteriophage + saccharomyces-boulardiiBacteriophages cannot infect yeast; entirely separate biological targets.
S. boulardii is a eukaryotic yeast and carries none of the bacterial surface structures a phage uses to attach. A phage preparation and a yeast probiotic are biologically independent in the same capsule. Independence is the claim here, nothing more.
T4D Myoviridae Bacteriophage + inulinPrebiotic fermentation changes the composition of the bacterial community the phage acts within.
Fermentable fructans feed saccharolytic genera and shift the community structure, including the abundance of the Gram-negative populations a coliphage can find. Phage predation depends on host density, so the substrate and the predator interact indirectly through the community. This is ecological reasoning from established microbiology, not a measured combination result.
T4D Myoviridae Bacteriophage + fos-fructooligosaccharidesSame ecological logic as other fermentable fructans.
Short-chain fructans are fermented in the proximal colon and shift which populations dominate there. Since a lytic phage needs a threshold density of its host to replicate, community composition sets the stage for what the phage can do. The mechanism is plausible and untested as a pair.
T4D Myoviridae Bacteriophage + gos-galactooligosaccharidesPrebiotic substrate effects on community composition.
Galactooligosaccharides selectively support bifidobacteria and shift the balance of the wider community. A coliphage operates inside that community and its host abundance moves with it. Read this as ecology rather than a tested combination.
T4D Myoviridae Bacteriophage + resistant-starchFermentable substrate that shifts colonic community structure and short-chain fatty acid output.
Resistant starch reaches the colon intact and is fermented to butyrate and other short-chain fatty acids, which lowers luminal pH and changes which genera thrive. That environment governs how much host population a phage encounters. Nothing measures the two together.
T4D Myoviridae Bacteriophage + sodium-bicarbonateEstablished acid lability of phage particles; buffering raises gastric pH during transit.
Phage capsids lose infectivity at low gastric pH, which is the central delivery problem for any oral phage preparation. An alkaline buffer taken with the dose raises stomach pH transiently and is one of the standard ways to improve survival to the intestine. The chemistry is settled; how much titre survives in practice depends on the formulation.
T4D Myoviridae Bacteriophage + betaine-hclDeliberate gastric acidification opposes phage particle survival.
Betaine hydrochloride is taken specifically to lower stomach pH, the condition that inactivates phage particles fastest. Taking the two in the same dose works against the phage preparation. Separating them in time is the straightforward answer.
T4D Myoviridae Bacteriophage + activated-charcoalNon-specific adsorption of proteins and particulates by activated carbon.
Activated charcoal adsorbs organic molecules and particulate matter indiscriminately in the gut lumen, and a phage is a protein-coated nucleic acid particle. Co-administration would be expected to reduce the number of viable particles reaching the colon. Spacing doses by several hours is the standard handling.
T4D Myoviridae Bacteriophage + bentonite-clayEstablished binding of viral particles and proteins to clay mineral surfaces.
Layered aluminosilicate clays bind viruses and proteins to their charged surfaces, a property used deliberately in water treatment. A phage preparation taken alongside a clay binder is a candidate for the same adsorption. This is surface chemistry rather than a tested supplement interaction.
T4D Myoviridae Bacteriophage + l-glutamineIndependent formulation rationale in gut-directed products.
Glutamine is a fuel for enterocytes and is included in gut formulas for normal barrier maintenance, while a phage acts on the bacterial community. The two occupy the same capsule for unrelated reasons. Nothing links them mechanistically.
T4D Myoviridae Bacteriophage + butyrateShort-chain fatty acid produced by the same community the phage operates in.
Butyrate is the main energy source for colonocytes and its concentration reflects the composition of the fermenting community. Any predation that shifts that community shifts butyrate output in some direction, which is not predictable in advance. Direct butyrate supplementation bypasses the community question entirely.
T4D Myoviridae Bacteriophage + lactoferrinEstablished iron sequestration that restricts growth of Gram-negative bacteria.
Lactoferrin binds free iron and also interacts with lipopolysaccharide on Gram-negative envelopes, which limits growth of the same populations a coliphage targets. The two act on overlapping populations by different routes. A phage needs actively growing host cells to replicate, so heavy growth restriction could in principle work against phage amplification, which makes the direction of the combined effect uncertain.
T4D Myoviridae Bacteriophage + colostrum-bovineImmunoglobulin content directed at enteric bacterial surface antigens.
Bovine colostrum carries secretory immunoglobulins that bind bacterial surface structures in the gut lumen. Formulators combine it with phage preparations in gut blends. Whether antibody coating of a host cell helps or hinders phage attachment is not established either way.
Who should be cautious
Talk to a doctor before taking T4D Myoviridae Bacteriophage if any of these apply to you: Limited oral supplementation data, Very specific target range. These are flags to check first, not effects T4D Myoviridae Bacteriophage is known to cause.
Not medical advice. Show the label to your pharmacist.Getting T4D Myoviridae Bacteriophage from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
Fermented foodsRaw water
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
Freeze-dried bacteriophage preparationPurified phage lysate freeze-dried with cryoprotectants such as trehalose or sucrose, titred in plaque-forming units.Fits Use in capsules and dry blends where shelf stability without refrigeration is needed.Trade-off Titre falls over shelf life and the drying step itself costs some viable particles, so overage is built in at manufacture.
Liquid phage concentrateClarified lysate held in a buffered salt solution at a controlled pH, without a drying step.Fits Use in liquid formats and where the drying loss is to be avoided.Trade-off Needs cold chain and a shorter shelf life than a dried powder, and cannot be pressed into a tablet.
Delayed-release phage capsuleDried preparation inside a pH-responsive polymer shell that stays closed in gastric acid and opens in the small intestine.Fits Use where survival through the stomach is the limiting step.Trade-off Adds a polymer excipient and shifts the release point downstream, which may not match where the target population sits.
Bacteriophage blendSeveral phages with different receptor specificities combined, so a receptor change in the host population does not defeat the whole preparation.Fits Use where breadth across bacterial strains matters more than a single defined component.Trade-off Each component needs its own titre and identity control, which makes characterisation and batch release more involved.
What the strongest studies found
The essence, in one line each.
- In adults, a supplemental bacteriophage preparation taken alongside Bifidobacterium animalis subsp. lactis BL04 was compared with the probiotic alone for effects on gut bacteria and digestive comfort.Randomised trial. Grubb et al., 2020 (Nutrients). PMID 32824480 ↗
- The review describes how bacteriophages sourced from natural environments are prepared for use in food supplements and sets out the host-specificity rationale for that use.Narrative review. Kiani et al., 2020 (Acta Biomedica: Atenei Parmensis). PMID 33170168 ↗
- The review sets out how phage predation shapes gut bacterial community composition, with most supporting evidence coming from culture and animal models rather than human outcome trials.Narrative review. Mahmud et al., 2024 (Gut Microbes). PMID 39167701 ↗
These are the studies our verdict leans on, chosen from the 7 we read for T4D Myoviridae Bacteriophage. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
